HKEX Insider Activity β 2026-07-10
ππ° HKEX DI Report β 2026-07-10
π NEW ENTRY β 9978 Fineland Living Services Group β Weili Gong / Yoncan Co. (his holding vehicle), 50.01% (first disclosed from nil)
Read: Gong and his wholly-owned vehicle Yoncan Co. filed simultaneous first-disclosures for the same 200.04M-share block at HKD 0.14/share (HKD 28.0M total), locking in a controlling majority stake in this property-management micro-cap.
π NEW ENTRY β 3661 SG Micro Corp β JPMorgan Asset Management Asia Pacific, 10.71% (first consolidated at 10.71%)
Read: JPMorgan AM Asia Pacific registered a 10.71% anchor stake in the H-shares of this Shenzhen analog-chip maker after a related sub-entity reclassification, with 5.78M shares valued at HKD 607.8M.
π NEW ENTRY β 1688 LINGYI iTECH (Guangdong) β J.P. Morgan Securities PLC, 5.64% (first consolidated at 5.64%; 26 Jun filing)
Read: J.P. Morgan Securities consolidated a fresh 5.64% position in LINGYI iTECH H-shares following a related-entity reclassification on 26 Jun, with 45.76M shares at avg. HKD 10.78 (HKD 493.3M) β a large block in this flexible-circuit electronics manufacturer.
π NEW ENTRY β 6067 Shenzhen Senior Technology Material β JPMorgan Chase & Co., 7.61% (increased by 6.50pp from prior filing)
Read: JPMorgan Chase's aggregate in this lithium-battery separator maker surged to 7.61% after a related sub-entity was reclassified into the group position, with 9.71M shares at avg. HKD 11.24 (HKD 109.2M).
π NEW ENTRY β 9630 Circuit Fabology Microelectronics Equipment β JPMorgan Asset Management Asia Pacific, 5.06% (first consolidated at 5.06%; 26 Jun filing)
Read: JPMorgan AM Asia Pacific reported a fresh 5.06% aggregate in this semiconductor equipment H-share after a sub-entity reclassification on 26 Jun, with 649,250 shares at avg. HKD 443.12 (HKD 287.7M).
π NEW ENTRY β 6821 Asymchem Laboratories β Barclays, 7.05% (increased by 3.30pp, crossing 5% threshold)
Read: Barclays crossed the mandatory 5% disclosure level in Asymchem H-shares with 917,400 shares at avg. HKD 113.83 (HKD 104.4M), establishing a new institutional position in this contract pharmaceutical development and manufacturing (CDMO) name.
π NEW ENTRY β 3696 InSilico Medicine β JPMorgan Chase & Co., 5.52% (increased by 0.81pp from prior filing)
Read: JPMorgan Chase reconsolidated its aggregate in this AI drug-discovery biotech to 5.52% after a related-entity reclassification, with 5.01M shares at avg. HKD 36.58 (HKD 183.2M).
π NEW ENTRY β 719 Shandong Xinhua Pharmaceutical β E Fund Management, 5.26% (increased by 0.70pp, crossing 5%)
Read: China's E Fund Management crossed the 5% reporting threshold in Shandong Xinhua Pharmaceutical H-shares with 1.38M shares at avg. HKD 6.09 (HKD 8.4M), establishing a first reportable position in this generic pharma name.
π NEW ENTRY β 1688 LINGYI iTECH (Guangdong) β JPMorgan Chase & Co., 5.41% (increased by 0.51pp; 7 Jul filing)
Read: The JPMorgan Chase parent separately filed a 5.41% consolidated LINGYI iTECH group position on 7 Jul, adding 4.09M shares at avg. HKD 9.04 (HKD 37.0M), confirming the JPMorgan group holds this name across multiple booking entities.
π NEW ENTRY β 2525 Hesai Group β BlackRock, 5.03% (increased by 0.36pp from prior filing)
Read: BlackRock's consolidated aggregate in this lidar-sensor maker re-cleared 5% at 5.03% after a related sub-entity reclassification β a structural reconsolidation rather than a fresh open-market purchase.
π NEW ENTRY β 1208 MMG β JPMorgan Chase & Co., 5.11% (increased by 0.18pp from prior filing)
Read: JPMorgan's consolidated stake in this China Minmetals copper-zinc miner edged to 5.11% after a related-entity reclassification, with 22.19M shares at avg. HKD 7.03 (HKD 155.9M).
π NEW ENTRY β 3636 Yunnan Jinxun Resources β OP Investment Management / Trivista Capital SPC (Trivista China SP I), 5.27% (increased by 0.31pp, crossing 5%)
Read: OP Investment Management and its Cayman fund vehicle Trivista Capital SPC simultaneously disclosed the same 130,000-share block β one economic interest, two regulatory filers β marking a fresh 5.27% first-entry into this small Yunnan natural-resources company.
π NEW ENTRY β 2145 Chicmax Cosmetic β BlackRock, 5.13% (increased by 0.15pp from prior filing)
Read: A BlackRock sub-entity reclassification nudged the group's consolidated stake in this Chinese prestige skincare brand to 5.13% β a minor structural filing at the reportable boundary.
π’ BUYBACK β 300 Midea Group β JPMorgan Chase & Co., 11.45% (decreased by 1.11pp from prior filing; issuer buyback)
Read: Midea Group's active repurchase programme triggered JPMorgan's disclosure; with 7.19M shares at avg. HKD 88.49 (HKD 636.5M) transacting during the period, the 1.11pp net decline signals JPMorgan was also a net seller alongside the company buyback.
π’ BUYBACK β 1772 Ganfeng Lithium β BlackRock, 6.92% (decreased by 1.10pp from prior filing; issuer buyback)
Read: Ganfeng's buyback programme triggered BlackRock's re-filing; the 1.10pp net decline to 6.92% implies BlackRock was a net seller into the company-supported price.
π’ BUYBACK β 1995 Ever Sunshine Services Group β BNY Mellon, 5.93% (decreased by 1.20pp from prior filing; issuer buyback)
Read: Ever Sunshine's repurchase activity triggered BNY Mellon's disclosure, with the stake sliding 1.20pp net to 5.93% β the steepest percentage-point drop across this batch.
π’ BUYBACK β 1138 COSCO SHIPPING Energy Transportation β BlackRock, 7.54% (decreased by 0.73pp from prior filing; issuer buyback)
Read: COSCO Energy's buyback reduced the total share count and triggered BlackRock's re-filing at 7.54%; the negative net delta implies BlackRock also trimmed its absolute position during the period.
π’ BUYBACK β 699 Ningbo Joyson Electronic β JPMorgan Chase & Co., 5.28% (decreased by 0.73pp from prior filing; issuer buyback)
Read: Joyson Electronic's repurchase triggered JPMorgan's disclosure; 1.13M shares at avg. HKD 13.48 (HKD 15.3M) transacted during the period, with the net position settling at 5.28%.
No redactions applied.
Published via wiis. Originals are encrypted at rest; this page reflects the redacted version. report abuse.
Discussion
No comments yet.